ColoradoIntroduced2026 Regular Session

SB26-130 Medical Spas Deceptive Trade Practices

Latest: Feb 25, 2026 · Senate Committee on Health & Human Services Postpone Indefinitely

Health care

What it means

Our plain-English summary and constitutional analysis for this bill is not published yet. Every analysis is reviewed by an editor before it appears here.

How they voted

1 committee, procedural and amendment vote

Senate: Postpone Senate Bill 26-130 indefinitely.

7 yes · 0 no

Apr 23, 2026 · Result: pass

PartyYes
Democratic5
Republican2
How each member voted (7)

Party shown is each member's current party in our records. Official vote record

Where it stands

  1. Feb 25, 2026 · Senate

    Introduced

    Introduced In Senate - Assigned to Health & Human Services

Full official history (2 actions)
  • Feb 25, 2026SenateIntroduced In Senate - Assigned to Health & Human Services
  • Apr 23, 2026SenateSenate Committee on Health & Human Services Postpone Indefinitely

Supporters and opponents

No documented positions yet. Every position we list links to its public source.

Official summary

Read the official summary (openstates)
The bill makes it an unfair or deceptive trade practice under the "Colorado Consumer Protection Act" for a facility or medical practice providing cosmetic, aesthetic, wellness, longevity, or lifestyle treatments involving the administration or use of prescription drugs, including injectable and sterile drug products (medical spa), to:Acquire or receive a prescription drug from a person not legally authorized to distribute or transfer the prescription drug;Fail to store, handle, prepare, or administer a prescription drug in accordance with manufacturer requirements, applicable federal and state law, or generally accepted standards of medical practice;Permit an individual to prescribe or administer prescription drugs outside the scope of the individual's state-issued credential;Fail to maintain reasonable safeguards to prevent contamination, diversion, theft, or misuse of prescription drugs;Represent that a prescription drug is safe or effective in a manner inconsistent with federal law or federal food and drug administration-approved labeling; has sponsorship, approval, characteristics, ingredients, uses, or benefits that it does not have; or is approved by the federal food and drug administration when it is not;Fail to designate a licensed health-care provider with prescriptive authority to provide clinical oversight of prescription drugs used at the medical spa; orFail to create, maintain, or produce to the attorney general or a district attorney records of serious adverse events involving patients.The attorney general or a district attorney may enforce a violation of a prohibited action specified in the bill. The attorney general may adopt rules to implement the bill.(Note: This summary applies to this bill as introduced.)